Ting Deng M.D.
Acting Director

Education:

MD, Tianjin Medical University (2013)

Expertise: Medical Oncology

Dr. Deng has been engaged in medical oncology for a long time. She is experienced in formulating neoadjuvant chemotherapy, adjuvant chemotherapy regimens for early stage cancer patients, and selecting palliative chemotherapy, targeted therapy and immunotherapy for advanced cancer patients. During the ten years of clinical practices, she has taken apart into more than 40 clinical trials, including phase I–III trials on various anti-tumor drugs.

Visiting time:

Monday mornings in the department of gastrointestinal medical oncology